BioMarin, Sarah Cannon Research UK Expand PARP Inhibitor Trial Outside US

 

IP Update: Recent Patents Awarded to City of Hope, Alnylam, and More

 

RXi Initiates Third Phase IIa Trial of Anti-scarring Drug

 

Duke Team Uncovers RNAi-based Drug-resistance Mechanism in Pathogenic Fungus

 

Illumina Continues Push into Oncology, Reproductive Health; Fine Tunes its 'Clinical Readiness' Strategy

 

Survey Highlights Successes and Challenges for Early Adopters of Clinical NGS

 

Sequenom Runs Nearly 41K MaterniT21 Tests; Reports Mixed Progress on Reimbursement

 

Recent Clinical Sequencing Papers of Note

 

People in the News: Greg Lucier, Vicky Gregg, Franz Och, Matt Brunner, More

 

New Products: Foundation Medicine's FoundationOne; Vitalité Health's Cancer Panel